Last week there were a handful of recalls due to the presence of NDEA. Here are the latest.
FDA posted four warning letters this week including one to an API manufacturer, one to a compounding pharmacy and one to a drug product manufacturer.
From lack of sterility to discoloration, here are the latest recalls.
We compiled last week's warning letters for you. Take a look.
From high concentrations of ibuprofen for infants to a metal shard found in a tablet, here are the latest recalls.
Last week, the FDA issued a warning letter after a study drug was administered even though the study had been placed on clinical hold.
From children’s allergy medicine to antacid tablets containing metal particles, here are the latest recalls.
From poor water quality to a hush-up of failing test results, we cover five warning letters the FDA sent to companies this week.
This week the FDA posted 4 new warning letters. One was issued to a cell/tissue product manufacturer, 1 to a firm for failure to list, 1 to a compounding pharmacy, and 1 to a device manufacturer. We cover 3 of these in this post.